<?xml version="1.0" encoding="UTF-8"?>
<p>In Kenya, DF has been reported since World War II (
 <xref rid="veaa026-B30" ref-type="bibr">McCarthy and Wilson 1948</xref>), with serological evidence recorded between 1966 and 1968 (
 <xref rid="veaa026-B15" ref-type="bibr">Geser, Henderson, and Christensen 1970</xref>) suggesting that the virus had been circulating in coastal Kenya during that time. However, it was not until 1982 that the first dengue outbreak was documented in the Coastal towns of Malindi and Kilifi, which was subsequently determined to have been driven by DENV-2 (
 <xref rid="veaa026-B19" ref-type="bibr">Johnson et al. 1982a,b</xref>). After this initial outbreak, no case of dengue disease was documented in this region for a period of almost two decades. In 1997, DENV-2 was isolated from a child with febrile illness in Kilifi, Kenya (
 <xref rid="veaa026-B43" ref-type="bibr">Sang and Dunster 2001</xref>), suggesting possible continued active transmission of DENV in the region. This was further reinforced by the detection in 2004 of DENV IgG antibodies from human serum in Malindi (
 <xref rid="veaa026-B31" ref-type="bibr">Mease et al. 2011</xref>). Between 2011 and 2014, an outbreak involving DENV-1, 2, and 3 was reported in Mandera, northeastern Kenya, and Mombasa, coastal Kenya (
 <xref rid="veaa026-B24" ref-type="bibr">Konongoi et al. 2016</xref>; 
 <xref rid="veaa026-B36" ref-type="bibr">Obonyo, Fidhow, and Ofula 2018</xref>). In 2017, another outbreak involving DENV-2 was reported in Wajir and Mandera in North Eastern Kenya as well as Malindi, Kilifi, and Mombasa, on the Kenyan Coast (
 <xref rid="veaa026-B61" ref-type="bibr">WHO 2017</xref>).
</p>
